Cargando…

Cost Effectiveness of New Diagnostic Tools for Cutaneous Leishmaniasis in Afghanistan

BACKGROUND AND OBJECTIVES: Cutaneous leishmaniasis is responsible for chronic and disfiguring skin lesions resulting in morbidity and social stigma. The gold standard to diagnose cutaneous leishmaniasis is microscopy but has a variable sensitivity and requires trained personnel. Using four scenarios...

Descripción completa

Detalles Bibliográficos
Autores principales: Aerts, Céline, Vink, Martijn, Pashtoon, Sayed Jalal, Nahzat, Sami, Picado, Albert, Cruz, Israel, Sicuri, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439180/
https://www.ncbi.nlm.nih.gov/pubmed/30465319
http://dx.doi.org/10.1007/s40258-018-0449-8
_version_ 1783407209244262400
author Aerts, Céline
Vink, Martijn
Pashtoon, Sayed Jalal
Nahzat, Sami
Picado, Albert
Cruz, Israel
Sicuri, Elisa
author_facet Aerts, Céline
Vink, Martijn
Pashtoon, Sayed Jalal
Nahzat, Sami
Picado, Albert
Cruz, Israel
Sicuri, Elisa
author_sort Aerts, Céline
collection PubMed
description BACKGROUND AND OBJECTIVES: Cutaneous leishmaniasis is responsible for chronic and disfiguring skin lesions resulting in morbidity and social stigma. The gold standard to diagnose cutaneous leishmaniasis is microscopy but has a variable sensitivity and requires trained personnel. Using four scenarios, the objective of this study is to compare the cost effectiveness of microscopy with two new tools: Loopamp™ Leishmania Detection Kit (LAMP) and CL Detect™ Rapid Test (RDT). METHODS: Data related to the cost and accuracy of these tools were collected at the clinic of the National Malaria and Leishmaniasis Control Program in Kabul, Afghanistan. The effectiveness estimates were measured based on the tools’ performance but also indirectly, using the disability-adjusted life years. A decision tree was designed in TreeAge Healthcare Pro 2016, combined with a Markov model representing the natural history of cutaneous leishmaniasis. In addition to a deterministic analysis, univariate sensitivity and probabilistic analyses were performed to test the robustness of the results. RESULTS: If the tools are compared at the National Malaria and Leishmaniasis Control Program level in a period of low incidence, microscopy remains the preferred option. LAMP becomes more appropriate during cutaneous leishmaniasis seasons or outbreaks when its capacity to process several tests (e.g. up to 48) at a time can be maximised. RDT has a cost similar to microscopy when used at the reference clinic but as it is relatively easy to use, it could be implemented at the peripheral level, which would become cheaper than employing microscopy at the reference clinic. Moreover, combining RDT with microscopy or LAMP at the reference clinic for the negative suspects is economically more interesting than directly performing LAMP or microscopy respectively on all cutaneous leishmaniasis suspects at the reference clinic. CONCLUSIONS: When taking advantage of their respective strengths, LAMP and RDT can prove to be cost-effective alternatives to using microscopy alone at the reference clinic. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40258-018-0449-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6439180
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-64391802019-04-15 Cost Effectiveness of New Diagnostic Tools for Cutaneous Leishmaniasis in Afghanistan Aerts, Céline Vink, Martijn Pashtoon, Sayed Jalal Nahzat, Sami Picado, Albert Cruz, Israel Sicuri, Elisa Appl Health Econ Health Policy Original Research Article BACKGROUND AND OBJECTIVES: Cutaneous leishmaniasis is responsible for chronic and disfiguring skin lesions resulting in morbidity and social stigma. The gold standard to diagnose cutaneous leishmaniasis is microscopy but has a variable sensitivity and requires trained personnel. Using four scenarios, the objective of this study is to compare the cost effectiveness of microscopy with two new tools: Loopamp™ Leishmania Detection Kit (LAMP) and CL Detect™ Rapid Test (RDT). METHODS: Data related to the cost and accuracy of these tools were collected at the clinic of the National Malaria and Leishmaniasis Control Program in Kabul, Afghanistan. The effectiveness estimates were measured based on the tools’ performance but also indirectly, using the disability-adjusted life years. A decision tree was designed in TreeAge Healthcare Pro 2016, combined with a Markov model representing the natural history of cutaneous leishmaniasis. In addition to a deterministic analysis, univariate sensitivity and probabilistic analyses were performed to test the robustness of the results. RESULTS: If the tools are compared at the National Malaria and Leishmaniasis Control Program level in a period of low incidence, microscopy remains the preferred option. LAMP becomes more appropriate during cutaneous leishmaniasis seasons or outbreaks when its capacity to process several tests (e.g. up to 48) at a time can be maximised. RDT has a cost similar to microscopy when used at the reference clinic but as it is relatively easy to use, it could be implemented at the peripheral level, which would become cheaper than employing microscopy at the reference clinic. Moreover, combining RDT with microscopy or LAMP at the reference clinic for the negative suspects is economically more interesting than directly performing LAMP or microscopy respectively on all cutaneous leishmaniasis suspects at the reference clinic. CONCLUSIONS: When taking advantage of their respective strengths, LAMP and RDT can prove to be cost-effective alternatives to using microscopy alone at the reference clinic. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40258-018-0449-8) contains supplementary material, which is available to authorized users. Springer International Publishing 2018-11-21 2019 /pmc/articles/PMC6439180/ /pubmed/30465319 http://dx.doi.org/10.1007/s40258-018-0449-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research Article
Aerts, Céline
Vink, Martijn
Pashtoon, Sayed Jalal
Nahzat, Sami
Picado, Albert
Cruz, Israel
Sicuri, Elisa
Cost Effectiveness of New Diagnostic Tools for Cutaneous Leishmaniasis in Afghanistan
title Cost Effectiveness of New Diagnostic Tools for Cutaneous Leishmaniasis in Afghanistan
title_full Cost Effectiveness of New Diagnostic Tools for Cutaneous Leishmaniasis in Afghanistan
title_fullStr Cost Effectiveness of New Diagnostic Tools for Cutaneous Leishmaniasis in Afghanistan
title_full_unstemmed Cost Effectiveness of New Diagnostic Tools for Cutaneous Leishmaniasis in Afghanistan
title_short Cost Effectiveness of New Diagnostic Tools for Cutaneous Leishmaniasis in Afghanistan
title_sort cost effectiveness of new diagnostic tools for cutaneous leishmaniasis in afghanistan
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439180/
https://www.ncbi.nlm.nih.gov/pubmed/30465319
http://dx.doi.org/10.1007/s40258-018-0449-8
work_keys_str_mv AT aertsceline costeffectivenessofnewdiagnostictoolsforcutaneousleishmaniasisinafghanistan
AT vinkmartijn costeffectivenessofnewdiagnostictoolsforcutaneousleishmaniasisinafghanistan
AT pashtoonsayedjalal costeffectivenessofnewdiagnostictoolsforcutaneousleishmaniasisinafghanistan
AT nahzatsami costeffectivenessofnewdiagnostictoolsforcutaneousleishmaniasisinafghanistan
AT picadoalbert costeffectivenessofnewdiagnostictoolsforcutaneousleishmaniasisinafghanistan
AT cruzisrael costeffectivenessofnewdiagnostictoolsforcutaneousleishmaniasisinafghanistan
AT sicurielisa costeffectivenessofnewdiagnostictoolsforcutaneousleishmaniasisinafghanistan